Julie Elaine Burke

Array ( [id] => 3949339 [patent_doc_number] => 05977303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Mammalian cell surface antigens' [patent_app_type] => 1 [patent_app_number] => 8/462738 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30057 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977303.pdf [firstpage_image] =>[orig_patent_app_number] => 462738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3748259 [patent_doc_number] => 05717072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Antibodies that are immunoreactive with interleukin-4 receptors' [patent_app_type] => 1 [patent_app_number] => 8/465169 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 38 [patent_no_of_words] => 25107 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/717/05717072.pdf [firstpage_image] =>[orig_patent_app_number] => 465169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088342 [patent_doc_number] => 06025473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Multidrug resistance proteins' [patent_app_type] => 1 [patent_app_number] => 8/461384 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 47120 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025473.pdf [firstpage_image] =>[orig_patent_app_number] => 461384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657031 [patent_doc_number] => 05627052 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Methods for the production of proteins with a desired function' [patent_app_type] => 1 [patent_app_number] => 8/464261 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14304 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627052.pdf [firstpage_image] =>[orig_patent_app_number] => 464261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810560 [patent_doc_number] => 05854399 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Antibodies specific for human cripto-related polypeptide CR-3' [patent_app_type] => 1 [patent_app_number] => 8/464023 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 16 [patent_no_of_words] => 5464 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854399.pdf [firstpage_image] =>[orig_patent_app_number] => 464023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352281 [patent_doc_number] => 06218149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Antibodies having modified carbohydrate content and methods of preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/458666 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218149.pdf [firstpage_image] =>[orig_patent_app_number] => 458666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642449 [patent_doc_number] => 05637288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Chimeric antibody for detection and therapy of infectious and inflammatory lesions' [patent_app_type] => 1 [patent_app_number] => 8/457134 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8351 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637288.pdf [firstpage_image] =>[orig_patent_app_number] => 457134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700250 [patent_doc_number] => 05677427 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Chimeric antibody for detection and therapy of infectious and inflammatory lesions' [patent_app_type] => 1 [patent_app_number] => 8/457138 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677427.pdf [firstpage_image] =>[orig_patent_app_number] => 457138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988844 [patent_doc_number] => 05910574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Human trk receptors and neurotrophic factor inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/457880 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 47 [patent_no_of_words] => 38616 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910574.pdf [firstpage_image] =>[orig_patent_app_number] => 457880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3546053 [patent_doc_number] => 05571513 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Anti-gp130 monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/455799 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7272 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571513.pdf [firstpage_image] =>[orig_patent_app_number] => 455799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3621516 [patent_doc_number] => 05620686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Antigen-antibody conjugates' [patent_app_type] => 1 [patent_app_number] => 8/454747 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2850 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620686.pdf [firstpage_image] =>[orig_patent_app_number] => 454747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810845 [patent_doc_number] => 05854417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Borna disease virus-specific DNA and proteins' [patent_app_type] => 1 [patent_app_number] => 8/455976 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5082 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854417.pdf [firstpage_image] =>[orig_patent_app_number] => 455976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732797 [patent_doc_number] => 05635601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Beta-8 integrin subunit antibodies' [patent_app_type] => 1 [patent_app_number] => 8/454455 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21876 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635601.pdf [firstpage_image] =>[orig_patent_app_number] => 454455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728314 [patent_doc_number] => 05700914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Purification of Factor VII' [patent_app_type] => 1 [patent_app_number] => 8/446671 [patent_app_country] => US [patent_app_date] => 1995-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3673 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700914.pdf [firstpage_image] =>[orig_patent_app_number] => 446671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4018528 [patent_doc_number] => 05906938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor' [patent_app_type] => 1 [patent_app_number] => 8/449139 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8786 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/906/05906938.pdf [firstpage_image] =>[orig_patent_app_number] => 449139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795287 [patent_doc_number] => 05780601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Method for purification of protein \"e\" from haemophilus influenzae' [patent_app_type] => 1 [patent_app_number] => 8/447653 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14069 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780601.pdf [firstpage_image] =>[orig_patent_app_number] => 447653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754649 [patent_doc_number] => 05851527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Method for antibody targeting of therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/445110 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10807 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851527.pdf [firstpage_image] =>[orig_patent_app_number] => 445110 [rel_patent_id] =>[rel_patent_doc_number] =>)